Skip to content

Study on Management of Timira simple myopia with Ayurvedic procedure vimala varti Anjana and oral drugs Triphladi compound and Yashada Bhasma

Evaluation of the efficacy of Vimala varti anjana and Triphaladi compound with and without Yashada bhasma in the management of Timira simple myopia an open labelled double arm randomised clinical trial - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076168
Enrollment
48
Registered
2024-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients presenting with classical features of Simple myopia after proper screening with the help of Snellens Chart Retinoscopy and Auto refractometry will be selected irrespective of Gender Occupation religion etc Patients having simple Myopia -0.50 DS to -3.00 DS

Exclusion criteria

Exclusion criteria: Hypermetropia Astigmatism Presbyopia Simple Myopia more than -3.00 DS Pathological Myopia Patient with any systemic disease like HTN DM TB etc Patient with any other ocular pathology like Cataract Glaucoma retinal pathology etc Functional Myopia Pregnant and Lactating Mother

Design outcomes

Primary

MeasureTime frame
0.50 D change in the Clinical Refraction in patients of Timira Simple MyopiaTimepoint: Before treatment the 2nd week the 4th week and 6th week

Secondary

MeasureTime frame
Change in the other clinical features of Timira that is netrasrava netrayas and netradaha 75percent improvement in the Clinical features in the patients of Timira Simple MyopiaTimepoint: Before treatment the 2nd week the 4th week and 6th week

Countries

India

Contacts

Public ContactDr Manjusha Rajagopala

All India Institute of Ayurveda

hod-shalakya@aiia.gov.in9560788850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026